A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma

Dave Singh; Rainard Fuhr; Nicholas P. Bird; Sarah Mole; Kelly Hardes; Yau Lun Man; Anthony Cahn; Steven W. Yancey; Isabelle J. Pouliquen

doi:10.1111/bcp.15002

A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma

Dave Singh, Rainard Fuhr, Nicholas P. Bird, Sarah Mole, Kelly Hardes, Yau Lun Man, Anthony Cahn, Steven W. Yancey, Isabelle J. Pouliquen

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	British Journal of Clinical Pharmacology
DOIs	https://doi.org/10.1111/bcp.15002
Publication status	Published - Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bcp.15002

Cite this

@article{9a8765ab604145cd9d1906faac6fed10,

title = "A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma",

author = "Dave Singh and Rainard Fuhr and Bird, {Nicholas P.} and Sarah Mole and Kelly Hardes and Man, {Yau Lun} and Anthony Cahn and Yancey, {Steven W.} and Pouliquen, {Isabelle J.}",

year = "2022",

month = feb,

doi = "10.1111/bcp.15002",

language = "Undefined",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "John Wiley & Sons Ltd",

}

TY - JOUR

T1 - A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma

AU - Singh, Dave

AU - Fuhr, Rainard

AU - Bird, Nicholas P.

AU - Mole, Sarah

AU - Hardes, Kelly

AU - Man, Yau Lun

AU - Cahn, Anthony

AU - Yancey, Steven W.

AU - Pouliquen, Isabelle J.

PY - 2022/2

Y1 - 2022/2

UR - https://doi.org/10.1111/bcp.15002

U2 - 10.1111/bcp.15002

DO - 10.1111/bcp.15002

M3 - Article

SN - 0306-5251

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

ER -

A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma

UN SDGs

Access to Document

Other files and links

Cite this